Skip to main content
. 2013 Dec 13;27(1):1–11. doi: 10.1111/joic.12080

Table 1.

Baseline Characteristics

All Impella Pre-PCI Impella Post-PCI
N = 154 (mean ± SD, median [IQR], or %) N = 63 (mean ± SD, median [IQR], or %) N = 91 (mean ± SD, median [IQR], or %) P-Value
Age, years 64.0 ± 12.7 66 ± 12 63 ± 13 0.12
Gender, male 71.4% 73.0% 70.3% 0.73
Hypertension 77.3% 82.3% 73.9% 0.23
Diabetes 44.6% 56.7% 36.4% 0.02
PVD 21.4% 32.2% 13.6% 0.008
COPD 15.9% 22.9% 10.7% 0.05
Stroke 9.4% 15.3% 5.1% 0.04
Renal Insufficiency 23.9% 27.9% 21.2% 0.35
Myocardial infarction 38.6% 43.3% 35.3% 0.33
STEMI 74.7% 55.6% 87.9% <0.0001
Prior CABG 14.2% 19.4% 10.5% 0.13
Prior PCI 38.5% 37.1% 39.5% 0.77
Preadmission cardiogenic shock 63.4% 63.5% 63.3% 0.98
Preadmission cardiac arrest 22.5% 15.5% 27.5% 0.1
Transfer admission 48.9% 57.1% 42.9% 0.09
Duration of shock (hours) 0.2
 <6 47.2% 40.4% 51.7%
 6–12 14.6% 19.3% 11.5%
 12–24 12.5% 8.8% 14.9%
 >24 25.7% 31.6% 21.8%
Anoxic brain damage 21.0% 19.6% 21.9% 0.74
Number of inotropes 1.6 ± 1.1 1.4 ± 1.1 1.7 ± 1.2 0.17
IABP prior to Impella 48.7% 34.9% 58.2% 0.004
Mechanical ventilation 65.5% 54.8% 73.3% 0.02
LVEF (%) 26.4 ± 13.4 25.6 ± 12.9 27.0 ± 13.8 0.56
Troponin, ng/mL 5.7 [0.6 23.1] 5.7 [0.9 24.7] 5.7 [0.4 23.3] 0.82
Serum creatinine, mg/dL 1.4 [1.1 2.0] 1.3 [1.1 2.0] 1.5 [1.1 1.9] 0.41
eGFR, mL/min/m2 49 [27.5 60] 49 [25 60] 48 [29.5 60] 0.91
Serum lactate, mmol/L 4.1 [2.4 7.2] 4.3 [1.6 10.2] 3.8 [2.5 5.9] 0.65
STS mortality score 21.7 ± 15.2 22.6 ± 14.4 21.0 ± 15.8 0.55
STS morbidity score 64.2 ± 18.2 67.1 ± 16.9 62.1 ± 18.9 0.11

CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; IABP, intra-aortic balloon pump; IQR, inter-quartile range; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; SD, standard deviation; STEMI, ST elevation myocardial infarction; STS, Society of Thoracic Surgeons.